111 results
8-K
EX-10.1
RVLPQ
RVL Pharmaceuticals plc
20 Oct 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
RVLPQ
RVL Pharmaceuticals plc
13 Oct 23
Termination of a Material Definitive Agreement
4:15pm
8-K
EX-10.1
RVLPQ
RVL Pharmaceuticals plc
18 Aug 23
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:06pm
10-Q
2023 Q2
EX-10.1
RVLPQ
RVL Pharmaceuticals plc
Quarterly report
14 Aug 23
9:15am
10-K
2022 FY
EX-10.26
RVLPQ
RVL Pharmaceuticals plc
Annual report
20 Mar 23
5:19pm
8-K
EX-10.1
ah9mg
4 Apr 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
qtrp7n9sah729vf36
10 Nov 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
fchz99j1cusfd0ia
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-10.2
wznzzw oz
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm